By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eddingpharm (Cayman) Inc. 

Wanchai  Hong Kong    China
Phone: n/a Fax: n/a



Company News
Cardiome Pharma Corp. (COM.TO) Expands Partnership With Eddingpharm (Cayman) Inc. To Commercialize AGGRASTAT In China 8/24/2015 6:13:23 AM
Cardiome Pharma Corp. (COM.TO) Partner Eddingpharm (Cayman) Inc. To Initiate BRINAVESS Phase I Study In China 7/24/2015 7:25:19 AM
FAES Farma Of Spain Forms China JV With Eddingpharm (Cayman) Inc. 6/1/2015 2:00:03 PM
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014 7:50:35 AM
Immutep S.A. And Eddingpharm (Cayman) Inc. Start Production Of Immufact® IMP321 At WuXi AppTec, Inc. In China 4/8/2014 1:36:01 PM
Week in Review: Eddingpharm (Cayman) Inc. Buys ACT Biotech Assets For $95 Million 1/13/2014 8:50:25 AM
Eddingpharm (Cayman) Inc. Acquired Global Rights To Oncology Assets, Including Telatinib, From ACT Biotech 1/8/2014 10:02:49 AM
Week in Review: Eddingpharm (Cayman) Inc. In-Licenses China Rights to Bone Drug for $2.7 Million Upfront 10/21/2013 8:47:07 AM
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. to Develop and Commercialise Its Anti-Rankl Nanobody in Greater China 10/18/2013 11:04:25 AM
Immutep S.A. and Eddingpharm (Cayman) Inc. Sign Agreement for Development of ImmuFact® IMP321 in China 10/7/2013 9:25:53 AM